Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Comparative Tnseq of Vibrio cholerae grown without and with tobramycin at 2% MIC for 50 generation

ABSTRACT: Antibiotics at 2% of the MIC are not lethal for bacteria but cause stress. We studied the contribution of each gene in the fitness of V. cholerae for growth in tobramycin 2%MIC.

ORGANISM(S): Vibrio cholerae

PROVIDER: GSE334274 | GEO | 2026/06/08

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

V. cholerae transcriptome without treatment and with indole or sub-MIC tobramycin

Project description:We study gene expression levels of V. cholerae N16961 hapR+ corrected strain in exponential phase without and with indole or tobramycin.

2021-08-26 | GSE182561 | GEO

V. cholerae transcriptome of WT and rluB deletion mutant with sub-MIC tobramycin

Project description:We study gene expression levels of V. cholerae N16961 hapR+ corrected strain in exponential phase with tobramycin.

2025-08-03 | GSE275802 | GEO

V. cholerae transcriptome of WT and vchM deletion mutant with sub-MIC tobramycin

Project description:We study gene expression levels of V. cholerae N16961 hapR+ corrected strain in exponential phase with tobramycin.

2025-02-03 | GSE275800 | GEO

V. cholerae transcriptome of WT and modification deletion mutants with sub-MIC tobramycin or ciprofloxacin

Project description:We study gene expression levels of V. cholerae N16961 hapR+ corrected strain in exponential phase with tobramycin or ciprofloxacin.

2025-06-18 | GSE275883 | GEO

V. cholerae transcriptome without treatment and with indole or sub-MIC tobramycin

Project description:V. cholerae transcriptome without treatment and with indole or sub-MIC tobramycin

| PRJNA756892 | ENA

Effect of sub-MIC tobramycin treatment on E. coli MG1655 WT and NCM3416

Project description:Effect of sub-MIC tobramycin treatment on E. coli MG1655 WT (strain classically used as WT strain) and NCM3416 (corrected rph strain). Comparison of genes expression without treatment (MH) in E. coli MG1655 WT and NCM3416.

2023-03-01 | GSE224240 | GEO

V. cholerae transcriptome of WT and rluB deletion mutant with sub-MIC tobramycin

Project description:V. cholerae transcriptome of WT and rluB deletion mutant with sub-MIC tobramycin

| PRJNA1152992 | ENA

V. cholerae transcriptome of WT and vchM deletion mutant with sub-MIC tobramycin

Project description:V. cholerae transcriptome of WT and vchM deletion mutant with sub-MIC tobramycin

| PRJNA1152996 | ENA

Identification of small molecule inhibitors of the Pathogen Box against Vibrio cholerae

Project description:Antimicrobial resistance (AMR) has become a serious public and economic threat. The rate of bacteria acquiring AMR surpasses the rate of new antibiotics discovery, projecting more deadly AMR infections in the future. The Pathogen Box is an open-source library of drug-like compounds that can be screened for antibiotic activity. We have screened molecules of the Pathogen Box against Vibrio cholerae, the cholera-causing pathogen, and successfully identified two compounds, MMV687807 and MMV675968, that inhibit growth. RNA-seq analyses of V. cholerae after incubation with each compound revealed that both compounds affect cellular functions on multiple levels including carbon metabolism, iron homeostasis, and biofilm formation. In addition, whole-genome sequencing analysis of spontaneous resistance mutants identified an efflux system that confers resistance to MMV687807. We also identified that the dihydrofolate reductase is the likely target of MMV675968 suggesting it acts as an analog of trimethoprim but with a minimum inhibitory concentration (MIC) 14-fold lower than trimethoprim in molar concentration. In summary, these two compounds that effectively inhibit V. cholerae and other bacteria may lead to the development of new antibiotics for better treatment of the cholera disease.

2021-11-18 | GSE185596 | GEO

V. cholerae transcriptome or deleted for the tgt gene in MH, supplemented or not with tobramycin or ciprofloxacin

Project description:We study gene expression levels of V. cholerae N16961 WT and tgt mutant strains in MH medium in the presence or not of sublethal concentration on tobramycin or ciprofloxacin

2022-10-03 | GSE214520 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data